Leukokinins — Clinical Entities of Neoplasia?
Leukokinins are high molecular weight polypeptides which our laboratory first described. They are potent pharmacological mediators released by an acid protease found in white cells and neoplastic cells. The name leukokinin is derived from leuko — or white cells, the initial source of the enzyme. However, they were also found in L-1210 cells, a human leukemia-derived tumor as well as other tumor cells. Since these polypeptides resembled brady-kinin in their pharmacological properties the class of peptides were named leukokinins.
KeywordsOvarian Carcinoma Ascites Fluid Fluid Accumulation Acid Protease Human Preparation
Unable to display preview. Download preview PDF.
- 2.Greenbaum, L.M. Cellular Kininogenases and Leukokinins. Int’l. Conf. on Chem. and Biol. of the Kallekrein-Kinin System in Health Disease. 1974, in press.Google Scholar
- 6.Spragg, J. The Plasma Kinin-Forming System. In Mediators of Inflammation. ed.: Weissman, J. Plenum Press, 1974.Google Scholar
- 7.Greenbaum, L.M. Cathepsin D-generated, Pharmacologically Active Peptides (Leukokinins) and Their Role in Ascites Fluid Accumulation. Cold Spring Harbor Laboratory Symposium on Proteases and Biological Control, 223, 1975.Google Scholar